Skin uptake and clearance of ciclopirox following topical application

Biopharmaceutics and Drug Disposition

Volumn 34, Issue 9, 2013, Pages 540-549

  Nair, Anroop B ^a   Singh, Kishan ^b   Al Dhubiab, Bandar E ^a   Attimarad, Mahesh ^a   Harsha, Sree ^a   Alhaider, Ibrahim A ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

^b MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

Author keywords

ciclopirox; dermatopharmacokinetics; elimination; in vivo; plasma; skin

Indexed keywords

CICLOPIROXOLAMINE;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RETENTION; DRUG UPTAKE; GEL; GUINEA PIG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; RAT; SKIN PERMEABILITY; STRATUM CORNEUM; WISTAR RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIFUNGAL AGENTS; PYRIDONES; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; SWINE;

EID: 84890571361     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1866     Document Type: Article

References (37)

1. Alberti I, Kalia YN, Naik A, Guy RH,. Assessment and prediction of the cutaneous bioavailability of topical terbinafine, in vivo, in man. Pharm Res 2001; 18: 1472-1475.
2. Shah VP, Behl CR, Flynn GL, et al,. Principles and criteria in the development and optimization of topical therapeutic products. Pharm Res 1992; 9: 1107-1111.
3. Russell LM, Guy RH,. Measurement and prediction of the rate and extent of drug delivery into and through the skin. Expert Opin Drug Deliv 2009; 6: 355-369.
4. Navidi W, Hutchinson A, N'Dri-Stempfer B, Bunge A,. Determining bioequivalence of topical dermatological drug products by tape-stripping. J Pharmacokinet Pharmacodyn 2008; 35: 337-348.
5. Nicoli S, Bunge AL, Delgado-Charro MB, Guy RH,. Dermatopharmacokinetics: factors influencing drug clearance from the stratum corneum. Pharm Res 2009; 26: 865-871.
6. Herkenne C, Alberti I, Naik A, et al,. In vivo methods for the assessment of topical drug bioavailability. Pharm Res 2008; 25: 87-103.
7. Shah VP, Flynn GL, Yacobi A, et al,. AAPS/FDA workshop report: bioequivalence of topical dermatological dosage forms-methods of evaluation of bioequivalence. Pharm Res 1998; 15: 167-171.
8. Pershing LK, Corlett JL, Nelson JL,. Comparison of dermatopharmacokinetic vs. clinical efficacy methods for bioequivalence assessment of miconazole nitrate vaginal cream, 2% in humans. Pharm Res 2002; 19: 270-277.
9. Herkenne C, Naik A, Kalia YN, et al,. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm Res 2006; 23: 1850-1856.
10. Stagni G, O'Donnell D, Liu YJ, et al,. Intradermal microdialysis: kinetics of iontophoretically delivered propranolol in forearm dermis. J Control Release 2000; 63: 331-339.
11. Incecayir T, Agabeyoglu I, Derici U, Sindel S,. Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods. Pharm Res 2011; 28: 2165-2175.
12. Siddoju S, Sachdeva V, Friden PM, et al,. Acyclovir skin depot characterization following in vivo iontophoretic delivery. Skin Res Technol 2011; 17: 234-244.
13. Sammeta SM, Vaka SR, Murthy SN,. Dermal drug levels of antibiotic (cephalexin) determined by electroporation and transcutaneous sampling (ETS) technique. J Pharm Sci 2009; 98: 2677-2685.
14. N'Dri-Stempfer B, Navidi WC, Guy RH, Bunge AL,. Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics. Pharm Res 2009; 26: 316-328.
15. Boix-Montanes A,. Relevance of equivalence assessment of topical products based on the dermatopharmacokinetics approach. Eur J Pharm Sci 2011; 42: 173-179.
16. Rougier A, Dupuis D, Lotte C, et al,. In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J Invest Dermatol 1983; 81: 275-278.
17. Rougier A, Dupuis D, Lotte C, Roguet R,. The measurement of the stratum corneum reservoir. A predictive method for in vivo percutaneous absorption studies: influence of application time. J Invest Dermatol 1985; 84: 66-68.
18. Rougier A, Lotte C, Dupuis D,. An original predictive method for In vivo percutaneous absorption studies. J Soc Cos Chem 1987; 38: 397-417.
19. Federal Register, Notice of the Department of Health and Human Services. Draft Guidance for Industry on Topical Dermatological Drug Product NDAs and ANDAs. Withdrawal Fed Reg 2002; 67: 35122-35123.
20. N'Dri-Stempfer B, Navidi W, Guy RH, Bunge AL,. Optimising metrics for the assessment of bioequivalence between topical drug products. Pharm Res 2008; 25: 1621-1630.
21. Narkar Y,. Bioequivalence for topical products-an update. Pharm Res 2010; 27: 2590-601.
22. Lademann J, Jacobi U, Surber C, et al,. The tape stripping procedure-evaluation of some critical parameters. Eur J Pharm Biopharm 2009; 72: 317-323.
23. Shukla C, Friden P, Juluru R, Stagni G,. In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations. J Pharm Sci 2009; 98: 917-925.
24. Sachdeva V, Kim HD, Friden PM, Banga AK,. Iontophoresis mediated in vivo intradermal delivery of terbinafine hydrochloride. Int J Pharm 2010; 393: 112-118.
25. Franz TJ, Lehman PA, Raney SG,. Use of excised human skin to assess the bioequivalence of topical products. Skin Pharmacol Physiol 2009; 22: 276-286.
26. Masini V, Bonte F, Meybeck A, Wepierre J,. Cutaneous bioavailability in hairless rats of tretinoin in liposomes or gel. J Pharm Sci 1993; 82: 17-21.
27. Yourick JJ, Jung CT, Bronaugh RL,. In vitro and in vivo percutaneous absorption of retinol from cosmetic formulations: significance of the skin reservoir and prediction of systemic absorption. Toxicol Appl Pharmacol 2008; 231: 117-121.
28. Nair AB, Singh K, Shinu P, et al,. A comprehensive study to evaluate the effect of constant low voltage iontophoresis on transungual delivery. Drug Dev Ind Pharm 2013; 39: 807-815.
29. Kim JH, Lee CL, Choi HK,. A method to measure the amount of drug penetrated across the nail plate. Pharm Res 2001; 18: 1468-1471.
30. Anroop B, Ghosh B, Parcha V, Khanam J,. Transdermal delivery of atenolol: effect of prodrugs and iontophoresis. Curr Drug Deliv 2009; 6: 280-290.
31. Nair A, Reddy C, Jacob S,. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis. Skin Res Technol 2009; 15: 187-194.
32. Jacobi U, Kaiser M, Richter H, et al,. The number of stratum corneum cell layers correlates with the pseudo-absorption of the corneocytes. Skin Pharmacol Physiol 2005; 18: 175-179.
33. Kassis V, Søndergaard J,. Heat-separation of normal human skin for epidermal and dermal prostaglandin analysis. Arch Dermatol Res 1982; 273: 301-306.
34. Nair AB, Vaka SR, Gupta S, et al,. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride. Pharm Dev Technol 2012; 17: 158-163.
35. Morgan CJ, Renwick AG, Friedmann PS,. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis. Br J Dermatol 2003; 148: 434-443.
36. Sekkat N, Kalia YN, Guy RH,. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci 2002; 91: 2376-2381.
37. Nair A, Vyas H, Shah J, Kumar A,. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Drug Deliv 2011; 18: 19-25.